首页 › 基金 › Redmile Group, LLC › EPRX
Redmile Group, LLC 对 EPRX 的持仓历史
EUPRAXIA PHARMACEUTICALS INC · 医疗保健
Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 EPRX(EUPRAXIA PHARMACEUTICALS INC)611,400 股,市值约 US$4.0M,约占其申报组合的 0.27%,在其申报持仓中市值排名第 35 位。 Redmile Group, LLC 最近 2 个申报季度中有 2 个季度披露了 EPRX 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Redmile Group, LLC 对 EPRX 的持仓演变
Redmile Group, LLC 于 Q1 2026 首次披露 EPRX 持仓:700,000 股(约 US$5.1M)。 在 2 次申报中,Redmile Group, LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 611,400 股、市值约 US$4.0M,环比减持 -88,600 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 700.00K | $5.07M | 新进 |
| Q2 2026 | 611.40K | $4.04M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 EPRX 与 13F 数据
EPRX(EUPRAXIA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 69 只申报持有 EPRX,申报仓位最大的包括:Vivo Capital, LLC (US$8.9M), PFM Health Sciences, LP (US$8.0M), GREAT POINT PARTNERS LLC (US$7.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 EPRX 的基金
- Vivo Capital, LLC 1.35M 股 · $8.92M · Q2 2026
- PFM Health Sciences, LP 1.21M 股 · $8.00M · Q2 2026
- GREAT POINT PARTNERS LLC 1.20M 股 · $7.93M · Q2 2026
- Ikarian Capital, LLC 809.74K 股 · $5.35M · Q2 2026
- Seven Fleet Capital Management LP 610.78K 股 · $4.04M · Q2 2026
- Velan Capital Investment Management LP 352.00K 股 · $2.33M · Q2 2026
- Aisling Capital Management LP 325.00K 股 · $2.15M · Q2 2026
- Ally Bridge Group (NY) LLC 252.18K 股 · $1.67M · Q2 2026
- Delaney Capital Management Ltd. 117.20K 股 · $767.86K · Q2 2026
- Lynx1 Capital Management LP 10.00K 股 · $66.10K · Q2 2026
更多关于 Redmile Group, LLC
常见问题
How long has Redmile Group, LLC held EPRX?
Redmile Group, LLC has disclosed EPRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Redmile Group, LLC's current position in EPRX?
As of Q2 2026, Redmile Group, LLC holds 611.40K shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), valued at $4.04M, representing 0.27% of its reported portfolio and ranking #35.
Has Redmile Group, LLC been buying or selling EPRX?
In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in EPRX.
Which other funds hold EPRX?
Other major institutional holders of EPRX include Vivo Capital, LLC, PFM Health Sciences, LP, GREAT POINT PARTNERS LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.